Presenter: Heather Zwickey, PhD

Original Date: November 6, 2021

A lot of research has been devoted to COVID over the past 20 months. In this seminar, we will examine the research related to COVID, Post-COVID Syndrome, and Autoimmunity. In the first part of the seminar, we will discuss what we know now about the immune response to COVID. We’ll include how having pre-existing inflammation can affect that response. We’ll then examine how the inflammatory response can impact existing autoimmunity. We will discuss whether COVID or COVID vaccines can trigger new autoimmunity, and how they impact existing autoimmunity.

We will then examine the role the microbiome plays in autoimmunity and how COVID affects the microbiome. We will examine whether post-COVID could be microbiome related, drawing relationships between post-COVID and Lyme disease. Finally, we will discuss therapeutic approaches to Post-COVID that are microbiome-centric.

This seminar will discuss the pharmaceuticals:

• Remdesiver.
• Ivermectin.
• Biologic anti-IL-6.
• Biologic anti-IL-1.
• Biologic anti-TNF.
• Pfizer vaccine.
• Moderna vaccine.
• J&J vaccine.
• vaccine boosters.
• Medications that impact microbiome.

1.0 Pharmacy and 0.5 General (Total 1.5 CEUs) approved by OBNM